Enteric fever, primarily caused by Salmonella Typhi and Paratyphi, remains a significant global health concern. Despite advancements in diagnostic tools and therapeutic strategies, the disease's management continues to pose challenges due to the emerging antibiotic resistance. This article outlines the updated approach to diagnosing and treating enteric fever.
Timely and accurate diagnosis of enteric fever is critical. Traditional culture methods, though considered the gold standard, are time-consuming and have low sensitivity. Therefore, serological tests like Widal and Typhidot have been widely used. However, their specificity and sensitivity have been questioned. Recent advancements include molecular techniques like PCR and next-generation sequencing, offering high sensitivity and specificity, though their application is limited in resource-poor settings.
Antibiotic therapy remains the mainstay of enteric fever treatment. However, the increasing prevalence of multi-drug resistant (MDR) and extensively drug-resistant (XDR) strains necessitates a change in the treatment approach. Fluoroquinolones, once considered first-line therapy, are now recommended as second-line due to resistance. Current guidelines suggest using azithromycin or ceftriaxone as first-line therapy for uncomplicated cases, while resistant cases may require newer agents like carbapenems.
Prevention strategies include improving sanitation, safe water supply, and vaccination. Ty21a and Vi polysaccharide vaccines have shown efficacy, though their protection is short-lived. The newly introduced conjugate vaccine (Typbar-TCV) offers longer protection and is recommended for endemic regions.
Enteric fever management requires an updated approach considering the changing epidemiological trends and emerging resistance. While newer diagnostic and therapeutic strategies offer hope, their application needs to be tailored to the local epidemiological and resource context. Furthermore, prevention through improved sanitation, safe water, and vaccination remains crucial in controlling the disease.
1.
Global warming could be driving up women's cancer risk, find researchers
2.
Blood tests can predict the risk of relapse after a bone marrow transplant in patients with acute myeloid leukemia.
3.
Survey shows cancer anxiety has impact well beyond the individual diagnosed
4.
MRI can save rectal cancer patients from surgery, study suggests
5.
Glioma Outcomes Shaped by Subtype More Than Tx Sequence
1.
Rehabilitation After Organ-Conserving Cancer Surgery
2.
Practical Breakthroughs in Oncology Across Clinical Settings
3.
Gynecologic Oncology: Advances, Education, and Clinical Excellence
4.
Breaking Down the Different Types of Lymphoma: What You Need to Know
5.
RNA-Targeting Chimeras in Cancer: Mechanisms, Clinical Advances, and Future Directions
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part II
2.
First Line Combination Therapy- The Overall Survival Data in NSCLC Patients
3.
Cancer Care: From Awareness to Recovery
4.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VII
5.
A Conclusive Discussion on CROWN Trial and the Dawn of a New Era in Frontline Management of ALK+ NSCLC
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation